Crisaborole is a topical phosphodiesterase-4 (PDE4) inhibitor used for the treatment of mild to moderate atopic dermatitis. It reduces inflammation by increasing intracellular cyclic adenosine monophosphate (cAMP) levels. It is grouped under the following drug class(es): PDE4 inhibitors. Its therapeutic use is listed as anti-inflammatories and dermatologicals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Staquis and Eucrisa. Its PubChem CID is 44591583.
Crisaborole
| CAS No | 906673-24-3 |
|---|---|
| Molecular Formula | C14H10BNO3 |
| Molecular Weight | 251.05 g/mol |
| Synonyms | 4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Crisaborole is a topical phosphodiesterase-4 (PDE4) inhibitor used for the treatment of mild to moderate atopic dermatitis. It reduces inflammation by increasing intracellular cyclic adenosine monophosphate (cAMP) levels.
The listed CAS number is 906673-24-3.
The listed molecular formula is C14H10BNO3.
The listed molecular weight is 251.05 g/mol.
4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile.
The source lists Staquis and Eucrisa.